Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia.
暂无分享,去创建一个
S. Bakker | M. D. de Borst | R. van Wijk | C. Gaillard | M. Eisenga | E. V. van Beers | A. Glenthøj | S. van Straaten | A. V. van Vuren